Novasep is a leading worldwide provider of integrated manufacturing solutions for the Life Science industries. We develop, market and operate innovative technologies from lab to industrial scale to produce biomolecules and synthetic molecules for the pharmaceutical, biopharmaceutical, agrochemical, fine chemical and industrial biotechnology markets.
Our offering includes: process development services, custom synthesis and biomanufacturing (outsourcing solutions), purification processes, equipment and consumables (insourcing solutions), fine chemicals and generic active pharmaceutical ingredients.
The company operates 12 R&D and manufacturing sites worldwide including six FDA inspected manufacturing plants. It employs approximately 1,200 people and had annual revenues of approx. EUR300 million in 2010.